Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000909012-06-000740
Filing Date
2006-06-28
Accepted
2006-06-28 17:23:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G t302660.txt SC 13G 10039
  Complete submission text file 0000909012-06-000740.txt   11723
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: SC 13G | Act: 34 | File No.: 005-49245 | Film No.: 06930926
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 1775 BROADWAY NEW YORK NY 10019
GAGNON NEIL (Filed by) CIK: 0001070170 (see all company filings)

Type: SC 13G